Home  »  Industry   »  Seelos Therapeutics Inc. (SEEL) down -31.90% since...

Seelos Therapeutics Inc. (SEEL) down -31.90% since start of the year

Seelos Therapeutics Inc. (NASDAQ: SEEL) is -31.90% lower on its value in year-to-date trading and has touched a low of $0.48 and a high of $2.79 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SEEL stock was last observed hovering at around $1.21 in the last trading session, with the day’s loss setting it -0.1% off its average median price target of $5.00 for the next 12 months. It is also 90.75% off the consensus price target high of $12.00 offered by 4 analysts, but current levels are 63.0% higher than the price target low of $3.00 for the same period.

Currently trading at $1.11, the stock is -7.44% and 7.27% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.53 million and changing -8.26% at the moment leaves the stock 9.49% off its SMA200. SEEL registered -41.58% loss for a year compared to 6-month gain of 23.07%.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


The stock witnessed a 10.45% loss in the last 1 month and extending the period to 3 months gives it a 68.18%, and is -21.28% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.28% over the week and 10.48% over the month.

Distance from 52-week low is 131.11% and -60.22% from its 52-week high.

Seelos Therapeutics Inc. (SEEL) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Seelos Therapeutics Inc. (SEEL) is a “Buy”. 4 analysts offering their recommendations for the stock have an average rating of 1.60, where 0 rate it as a Hold and 0 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Seelos Therapeutics Inc. is expected to release its quarterly report on 11/04/2022.The EPS is expected to shrink by -70.30% this year.

Seelos Therapeutics Inc. (SEEL) Top Institutional Holders

The shares outstanding are 106.07M, and float is at 101.57M with Short Float at 5.56%.

Seelos Therapeutics Inc. (SEEL) Insider Activity

A total of 3 insider transactions have happened at Seelos Therapeutics Inc. (SEEL) in the last six months, with sales accounting for 0 and purchases happening 3 times. The most recent transaction is an insider purchase by O’Connor Daniel J.,the company’sDirector. SEC filings show that O’Connor Daniel J. bought 16,000 shares of the company’s common stock on Jun 01 at a price of $0.61 per share for a total of $9789.0. Following the purchase, the insider now owns 16000.0 shares.

Seelos Therapeutics Inc. disclosed in a document filed with the SEC on Mar 31 that Mehra Rajbought a total of 66,667 shares of the company’s common stock. The trade occurred on Mar 31 and was made at $0.85 per share for $56840.0. Following the transaction, the insider now directly holds 3.28 million shares of the SEEL stock.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.